Lyrebird

Who founded Lyrebird and who funds it?

Lyrebird Health was founded in early 2023 in Melbourne by Kai Van Lieshout and Linus Talacko, according to CB Insights and PitchBook. One aggregator gives 2024. PitchBook dates a Series A of 12M to May 22, 2025, led by Five V Capital and Octopus Ventures with Startmate. The currency is probably AUD, and PitchBook shows about US$7.8M. It also lists a seed round in December 2024. MobiHealthNews reported that the money was meant for UK expansion, regulatory compliance and EMR integration. The legal entity and ABN are not published on the site.

The vendor says thousands of clinicians use it. A Medical Republic survey puts Lyrebird and Heidi at about 95% of the Australian GP AI scribe market combined.

What does Lyrebird write?

The vendor describes ambient capture of the consult, a draft note in under 20 seconds, a dictation mode, and referrals, summaries, certificates and reports. It says the tool learns from your edits and from example documents you upload. It also prepares forms common in Australian general practice: CCMP, MHTP, Centrelink, WorkCover and NDIS PDFs. A Patient Summary view shows medications, allergies and history.

On data, the vendor says everything is processed and stored in Australia, no audio is stored and notes are never used to train external models. It describes itself as aligned with APP, HIPAA and GDPR, which is alignment and not certification. The page cites no SOC 2 or ISO 27001 certificate. Its FAQ calls the product fully compliant with TGA rules and shows no registration number. The TGA reviewed 12 digital scribes and found 8 likely meet the medical device definition without naming them, so whether Lyrebird is among the 8 is unknown. No FDA clearance for Lyrebird appears in openFDA.

How much does it cost?

The pricing page labels no currency, and the GST on the clinic plans points to AUD. There is a Free plan, and a Best Practice Free plan included via Best Practice, subject to eligibility. Pro is $160 a month, and the toggle shows $1,920 billed annually with a "Save 33%" label. Pro has a 14-day free trial.

Clinic plans are quoted plus GST per month and paid annually: Essentials from $299, Starter from $799, Standard from $1,099 and Premium from $1,649. Enterprise is custom, and the vendor says part-time clinicians, registrars and multi-clinician practices may get discounts through sales. The comparison site Aivy says the free plan allows 50 actions a month, while Lyrebird's page states no limit.

What do studies and users say?

Two 2026 papers involve Lyrebird. An ANZ Journal of Surgery quasi-experimental pilot in a regional general surgery clinic compared AI-assisted scribing with Lyrebird against traditional dictation (PMID 42253160). An ophthalmology paper in Eye tested six scribing tools, Lyrebird among them, on simulated encounters (PMID 41776297).

The vendor's Gold Coast Health case study covers 100+ clinicians across 21 specialties and reports an 80% cut in post-consult documentation time for some clinicians, 88% improved note quality, 84% improved workflow efficiency and 68% of patients noticing more engagement. No method is given.

Trustpilot shows 4.4 out of 5 from 33 reviews, none in the last 12 months. On March 31, 2025 one reviewer said it "transformed my consultations", and on April 1, 2025 another wrote that it "drastically reduced the amount of time completing notes and admin". A 2-star reviewer wrote of "lots transcription errors- and you do not catch all", and a 3-star reviewer said they had complained many times without a fix.

The verdict

Lyrebird is made for Australian GPs on Best Practice or Genie, and the market-share survey says many already use it. Aivy, a comparison site that may not be neutral, calls it the obvious GP pick on Best Practice and a weaker fit elsewhere.